Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATYR PHARMA, INC.

(LIFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 14,916,239,5224--
Entreprise Value (EV)1 14,916,239,5224224224
P/E ratio -0,43x-0,59x-2,19x-4,49x-4,77x-4,79x
Yield ------
Capitalization / Revenue -38,4x3,78x89,0x53,1x28,6x
EV / Revenue -38,4x3,78x89,0x53,1x28,6x
EV / EBITDA --0,73x-2,58x-6,42x-8,39x-10,1x
Price to Book ------
Nbr of stocks (in thousands) 2 1453 89010 18527 791--
Reference price (USD) 6,944,173,888,068,068,06
Announcement Date 03/25/201903/26/202003/23/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 -0,4210,52,524,227,84
EBITDA1 --22,3-15,3-34,9-26,7-22,1
Operating profit (EBIT)1 --23,0-15,9-33,6-41,0-45,7
Operating Margin --5 445%-152%-1 335%-971%-583%
Pre-Tax Profit (EBT)1 --23,8-16,2-32,8-40,7-45,4
Net income1 --23,6-16,2-32,8-40,7-45,4
Net margin --5 593%-155%-1 302%-966%-579%
EPS2 -16,1-7,03-1,77-1,79-1,69-1,68
Dividend per Share ------
Announcement Date 03/25/201903/26/202003/23/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 ---2,52--
EBITDA1 -7,08-10,3-7,61-9,50--
Operating profit (EBIT)1 -7,20-10,4-7,73-7,32-10,7-11,5
Operating Margin ----291%--
Pre-Tax Profit (EBT)1 -7,16-10,4-7,67-7,54-10,7-11,4
Net income1 -7,15-10,4-7,67-7,54-10,7-11,4
Net margin ----300%--
EPS2 -0,51-0,64-0,42-0,28-0,45-0,47
Dividend per Share ------
Announcement Date 05/13/202108/10/202111/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 --20,6-14,1-40,7-43,7-50,7
ROE (Net Profit / Equities) --86,1%----
Shareholders' equity1 -27,4----
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 -0,08-0,110,320,42
Capex / Sales -18,7%-4,49%7,58%5,40%
Announcement Date 03/25/201903/26/202003/23/2021---
1 USD in Million
Key data
Capitalization (USD) 223 992 856
Net sales (USD) 10 455 000
Number of employees 42
Sales / Employee (USD) 248 929
Free-Float 97,7%
Free-Float capitalization (USD) 218 780 656
Avg. Exchange 20 sessions (USD) 2 079 196
Average Daily Capital Traded 0,93%
EPS & Dividend